Alembic Pharmaceuticals Ltd

NSE :APLLTD BSE :533573 Sector : Pharmaceuticals

Buy, Sell or Hold APLLTD? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

06 Sep
1105.70
(-3.61%)

05 Sep
1147.15
(2.77%)

04 Sep
1116.20
(4.63%)

03 Sep
1066.85
(-0.29%)

02 Sep
1069.90
(1.02%)

30 Aug
1059.10
(0.86%)

29 Aug
1050.05
(-1.60%)

28 Aug
1067.15
(-0.19%)

27 Aug
1069.15
(-2.41%)

26 Aug
1095.55
(-0.52%)

23 Aug
1101.25
(-1.46%)

22 Aug
1117.60
(0.93%)

21 Aug
1107.25
(2.16%)

20 Aug
1083.80
(1.20%)

19 Aug
1070.95
(-1.70%)

16 Aug
1089.45
(2.57%)

14 Aug
1062.15
(-0.56%)

13 Aug
1068.15
(-3.84%)

12 Aug
1110.80
(-1.73%)

09 Aug
1130.35
(-6.89%)

08 Aug
1214.00
(-0.52%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bullish

1101.45

10 DMA

Bullish

1084.37

20 DMA

Bullish

1089.1

50 DMA

Bullish

1082.98

100 DMA

Bullish

1012.19

200 DMA

Bullish

955.93

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Sep 06, 2024 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	1226.96	1200.93	1125.95	-	-
R2	1200.93	1172.8	1119.2	1195.54	-
R1	1153.31	1155.41	1112.45	1142.53	1177.13
P	1127.28	1127.28	1127.28	1121.89	1139.19
S1	1079.66	1099.15	1098.95	1068.88	1103.48
S2	1053.63	1081.76	1092.2	1048.24	-
S3	1006.01	1053.63	1085.45	-	-

Key Metrics

EPS

37.91

P/E

29.22

P/B

4.44

Dividend Yield

0.99%

Market Cap

21,734 Cr.

Face Value

2

Book Value

249.74

ROE

13.4%

EBITDA Growth

238.25 Cr.

Debt/Equity

0.13 Shareholding Pattern

	69.61%	Total Promoter Holding

	8.05%	Mutual Fund Holdings

	4.32%	FIIs

	10.6%	Non Institution

	6.98%	Insurance Companies

	0%	Custodians

	0.44%	Other Parties

Shareholding History

Alembic Pharmaceuticals Ltd Quaterly Results

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
INCOME	1497.82	1605.08	1633.46	1520.58	1564.15
PROFIT	120.6	136.56	180.45	178.21	134.71
EPS	6.14	6.95	9.23	8.48	6.84

Alembic Pharmaceuticals Ltd Quaterly Results

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
INCOME	1344.11	1487.79	1591.69	1481.77	1478.71
PROFIT	97.53	133.84	233.24	201.87	176.19
EPS	4.96	6.81	11.87	10.27	8.96

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Alembic Pharmaceuticals Ltd Profit & Loss

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
INCOME	2133.34	3269.05	3177.12	3179.9	4036.33	4821.28	5674.35	5404.72	5576.71	6399.77
PROFIT	282.92	720.05	403.59	408.91	582.26	861.88	1141.34	518.23	345.93	612.84
EPS	14.28	38.2	21.59	22.33	31.44	42.47	56.72	26.5	17.4	31.33

Alembic Pharmaceuticals Ltd Profit & Loss

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
INCOME	2094.48	3111.78	3036.4	2988.11	3747.11	4443.8	5311.44	5066.7	5079.7	5957.74
PROFIT	286.61	698.71	430.58	418.2	609.06	976.46	1091.34	540.74	346.68	665.49
EPS	14.49	37.07	22.85	22.39	32.42	51.43	55.79	27.65	17.64	33.91

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
SOURCES OF FUNDS :
Share Capital	39.31	39.31	39.31	39.31	37.7	37.7	37.7	37.7	37.7	37.7
Reserves Total	4,778.89	4,331.16	5,198.23	5,027.66	3,181.71	2,681.12	2,182.44	1,864.63	1,559.66	846.94
Total Shareholders Funds	4,818.2	4,370.47	5,237.54	5,066.97	3,219.41	2,718.82	2,220.14	1,902.33	1,597.36	884.64
Minority Interest	0	0	0	0	-28.96	-0.79	0.31	0.11	0	0
Secured Loans	100.04	165.07	0	0.02	0.04	34.93	46.53	8.27	113.71	233.5
Unsecured Loans	413.12	556.95	717.11	583.59	1,747.45	1,093.5	661.25	80.24	0	30
Total Debt	513.16	722.02	717.11	583.61	1,747.49	1,128.43	707.78	88.51	113.71	263.5
Other Liabilities	109.51	106.2	95.82	85.52	147.81	52.03	40.76	57.22	41.28	22.21
Total Liabilities	5,440.87	5,198.69	6,050.47	5,736.1	5,085.75	3,898.49	2,968.99	2,048.17	1,752.35	1,170.35
APPLICATION OF FUNDS :
Gross Block	3,875.19	3,467.5	2,840.34	2,545.41	2,132.42	1,522.57	1,242.44	950.09	1,093.63	861.06
Less: Accumulated Depreciation	1,328.48	1,069.05	1,042.49	756.99	580.58	364.12	249.06	150.69	385.54	314.19
Net Block	2,546.71	2,398.45	1,797.85	1,788.42	1,551.84	1,158.45	993.38	799.4	708.09	546.87
Capital Work in Progress	524.36	601.28	2,304.23	2,182.53	1,846.18	1,551.23	1,010.15	396.28	92.52	83.14
Investments	93.02	96.33	118.4	236.28	17.62	48.76	41.64	49.88	86.73	2.26
Inventories	1,643.54	1,475.27	1,609.7	1,486.15	1,187.53	967.26	733.93	632.75	569.79	382.77
Sundry Debtors	1,024.84	1,046.4	807.13	348.58	864.75	488.92	526.34	338.82	350.48	361.17
Cash and Bank Balance	126.57	82.27	69.43	105.84	80.75	205.62	89.92	159.6	450.83	26.83
Loans and Advances	283.61	306.08	374.53	524.48	329.72	295.96	474.55	241.29	140.17	119.97
Total Current Assets	3,078.56	2,910.02	2,860.79	2,465.05	2,462.75	1,957.76	1,824.74	1,372.46	1,511.27	890.74
Current Liabilities	939.46	914.08	1,007.92	914.53	852.92	824.56	902.2	582.01	617.45	344.51
Provisions	65.25	70.06	63.64	54.14	38.19	36	34.4	22.15	16.03	94.88
Total Current Liabilities & Provisions	1,004.71	984.14	1,071.56	968.67	891.11	860.56	936.6	604.16	633.48	439.39
Net Current Assets	2,073.85	1,925.88	1,789.23	1,496.38	1,571.64	1,097.2	888.14	768.3	877.79	451.34
Deferred Tax Assets	300.92	206.15	203.57	184.71	148.06	122.12	83.04	55.3	23.81	16.25
Deferred Tax Liability	131.28	83.14	197.69	188.92	160.25	140.86	118.5	92.23	66.55	47.68
Net Deferred Tax	169.64	123.01	5.88	-4.21	-12.19	-18.74	-35.46	-36.93	-42.74	-31.43
Other Assets	33.29	53.74	34.88	36.7	110.66	61.59	71.14	71.24	29.96	118.15
Total Assets	5,440.87	5,198.69	6,050.47	5,736.1	5,085.75	3,898.49	2,968.99	2,048.17	1,752.35	1,170.33
Contingent Liabilities	54.61	109.23	62.87	100.46	117.8	103.98	94.04	82.07	108.61	104.84

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
SOURCES OF FUNDS :
Share Capital	39.31	39.31	39.31	39.31	37.7	37.7	37.7	37.7	37.7	37.7
Reserves Total	4,869.6	4,374.99	5,251.03	5,062.5	3,308.31	2,674.71	2,156.94	1,829.62	1,493.04	795.86
Total Shareholders Funds	4,908.91	4,414.3	5,290.34	5,101.81	3,346.01	2,712.41	2,194.64	1,867.32	1,530.74	833.56
Secured Loans	100.04	165.07	0	0.02	0.04	34.93	46.53	8.28	0	163.61
Unsecured Loans	391.95	544.86	706.12	583.59	1,686.99	1,024.35	575	0	0	30
Total Debt	491.99	709.93	706.12	583.61	1,687.03	1,059.28	621.53	8.28	0	193.61
Other Liabilities	109.51	106.2	95.82	85.52	146.51	51.33	40.43	57.22	41.28	22.21
Total Liabilities	5,510.41	5,230.43	6,092.28	5,770.94	5,179.55	3,823.02	2,856.6	1,932.82	1,572.02	1,049.38
APPLICATION OF FUNDS :
Gross Block	3,859.15	3,441.27	2,733.1	2,452.31	1,761.67	1,435.06	1,162.61	948.64	1,082.44	802.85
Less : Accumulated Depreciation	1,323.49	1,063.82	962	678.49	485.21	349.62	244.31	149.63	385.19	314.17
Net Block	2,535.66	2,377.45	1,771.1	1,773.82	1,276.46	1,085.44	918.3	799.01	697.25	488.68
Capital Work in Progress	524.36	601.28	2,304.23	2,182.53	1,569.98	1,106.89	740.64	347.75	92.34	83.14
Investments	226.68	229.27	219.36	343.09	833.25	506.39	298.89	103.04	37.46	33.33
Inventories	1,353.07	1,275.13	1,396.83	1,341.96	1,073.18	891.41	669.93	574.62	533.72	382.48
Sundry Debtors	1,340.12	1,201.2	988.33	421.86	784.11	539.78	621.66	467.41	371.5	337.94
Cash and Bank Balance	26.49	28.46	21.9	61.44	37.13	150.8	15.63	7.21	284.81	4.41
Loans and Advances	268.87	275.43	337.41	482.37	256.95	254.04	368.47	173.56	134.69	116.15
Total Current Assets	2,988.55	2,780.22	2,744.47	2,307.63	2,151.37	1,836.03	1,675.69	1,222.8	1,324.72	840.98
Current Liabilities	823.25	830.03	871.72	772.7	615.29	648.4	742.25	510.46	551.08	335.75
Provisions	64.88	69.96	63.64	53.71	38.17	32.37	34.4	22.07	16	94.6
Total Current Liabilities & Provisions	888.13	899.99	935.36	826.41	653.46	680.77	776.65	532.53	567.08	430.35
Net Current Assets	2,100.42	1,880.23	1,809.11	1,481.22	1,497.91	1,155.26	899.04	690.27	757.64	410.63
Deferred Tax Assets	210.11	161.3	151.29	142.8	114.49	95.59	73.86	48.45	23.7	16.25
Deferred Tax Liability	131.28	83.14	197.69	188.92	160.25	140.86	118.5	92.23	66.33	47.68
Net Deferred Tax	78.83	78.16	-46.4	-46.12	-45.76	-45.27	-44.64	-43.78	-42.63	-31.43
Other Assets	44.46	64.04	34.88	36.4	47.71	14.31	44.37	36.53	29.96	65.03
Total Assets	5,510.41	5,230.43	6,092.28	5,770.94	5,179.55	3,823.02	2,856.6	1,932.82	1,572.02	1,049.38
Contingent Liabilities	65.03	117.45	62.87	100.46	190.28	259.35	196.18	167.59	223.24	104.84

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 803.2

Net Profit before Tax and Extr...	631.83
Depreciation	272.67
Interest (Net)	54.1
Dividend Received	1.64
Prov. and W/O (Net)	5.37
P/L in Forex	-40.16
Others	-0.01
Total Adjustments (PBT and Ext...	286.86
Operating Profit before Workin...	918.69
Trade and 0ther Receivables	39.05
Inventories	-168.28
Trade Payables	56.04
Total Adjustments (OP before W...	-95.64
Cash Generated from/(used in) ...	823.05
Direct Taxes Paid	-19.85
Total Adjustments(Cash Generat...	-19.85
Cash Flow before Extraordinary...	803.2
Net Cash from Operating Activi...	803.2

Cash from Investing Activity -320.61

Purchased of Fixed Assets	-327.47
Sale of Fixed Assets	11.56
Purchase of Investments	-8.33
Interest Received	1.99
Net Cash used in Investing Act...	-320.61

Cash from Financing Activity -437.86

Of the Short Term Borrowings	-205.41
Of Financial Liabilities	-25.82
Dividend Paid	-157.25
Interest Paid	-49.37
Net Cash used in Financing Act...	-437.86

Cash from Operating Activity 772.77

Net Profit before Tax and Extr...	704.23
Depreciation	271.14
Interest (Net)	51.67
Dividend Received	1.64
P/L on Sales of Assets	0.58
Prov. and W/O (Net)	5.37
P/L in Forex	-40.15
Others	-0.01
Total Adjustments (PBT and Ext...	284.21
Operating Profit before Workin...	988.44
Trade and 0ther Receivables	-127.21
Inventories	-77.94
Trade Payables	24.31
Total Adjustments (OP before W...	-205.64
Cash Generated from/(used in) ...	782.8
Direct Taxes Paid	-10.03
Total Adjustments(Cash Generat...	-10.03
Cash Flow before Extraordinary...	772.77
Net Cash from Operating Activi...	772.77

Cash from Investing Activity -329.02

Purchased of Fixed Assets	-324.52
Sale of Fixed Assets	0.19
Interest Received	1.99
Invest.In Subsidiaires	-8.32
Net Cash used in Investing Act...	-329.02

Cash from Financing Activity -445.29

Of the Short Term Borrowings	-215.04
Of Financial Liabilities	-24.25
Dividend Paid	-157.25
Interest Paid	-48.74
Net Cash used in Financing Act...	-445.29

Company Details

Registered Office
Address	Alembic Road,
City	Vadodara
State	Gujarat
Pin Code	390003
Tel. No.	91-0265-2280550
Fax. No.	91-0265-2282506
Email	apl.investors@alembic.co.in
Internet	http://www.alembic-india.com

Registrars
Address	Alembic Road
City	Vadodara
State	Gujarat
Pin Code	390003
Tel. No.	91-0265-2280550
Fax. No.	91-0265-2282506
Email	apl.investors@alembic.co.in
Internet	http://www.alembic-india.com

Management
Name	Designation
Chirayu R Amin	Chairman & CEO
Rajkumar Baheti	Director (Finance) & CFO
Pranav Amin	Managing Director
Shaunak Amin	Managing Director
Archana Hingorani	Independent Director
Ashok Barat	Independent Director
Manisha Saraf	Company Sec. & Compli. Officer
Jai S Diwanji	Independent Director
Manish Kejriwal	Independent Director

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Alembic Pharmaceuticals Ltd

Buy, Sell or Hold APLLTD? Ask The Analyst

BSE

NSE

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Very Bullish

Long Term Investors

Very Bullish

Moving Averages

5 DMA

Bullish

10 DMA

Bullish

20 DMA

Bullish

50 DMA

Bullish

100 DMA

Bullish

200 DMA

Bullish

Intraday Support and Resistance (Based on Pivot Points) |

Key Metrics

EPS

37.91

P/E

29.22

P/B

4.44

Dividend Yield

0.99%

Market Cap

21,734 Cr.

Face Value

2

Book Value

249.74

ROE

13.4%

EBITDA Growth

238.25 Cr.

Debt/Equity

0.13

Shareholding Pattern

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Alembic Pharmaceuticals Ltd Quaterly Results

Alembic Pharmaceuticals Ltd Quaterly Results

Profit & Loss (Figures in Rs. Crores)

Alembic Pharmaceuticals Ltd Profit & Loss

Alembic Pharmaceuticals Ltd Profit & Loss

Balance Sheet (Figures in Rs. Crores)

Cash Flow (Figures in Rs. Crores)

Company Details

Registered Office

Registrars

Management

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Intraday Support and Resistance
(Based on Pivot Points) |